We're pleased that Zeeks is partnering with Convenzis as a media partner, supporting its upcoming programme of NHS healthcare events and helping share the ideas, insights and practical experiences coming out of these conversations. We recently spoke to Sean McLaughlin, Director of Convenzis Group, to find out more about Convenzis, why healthcare events are changing and who should be attending.

The cell and gene therapy landscape is evolving. Directly editing the genome or subcellular processes isn’t an aspirational dream anymore, but a potentially game-changing class of therapeutics for life-threatening and seriously debilitating diseases. Zeeks was fortunate enough to attend ELRIG’s Cell and Gene Therapy conference in Cambridge, hearing from the scientists developing cell and gene therapies about innovations in development across a plethora of diseases and therape

ELRIG is a scientific association that predominantly organises science conferences. It has become a hub for the drug discovery community, from academics to commercial partners and medicine developers, all with a mission to foster open access to modern research and innovation. As a company in the centre of the rapidly changing landscape of drug discovery, including cell and gene therapies, AI in medicine development, and the emerging geographies, we spoke with Sanj Kumar,